A review of CBD science following Malawi's 2020 cannabis legalization highlights its established use in epilepsy and emerging evidence for neuroprotection, including a novel proposal for malaria-related brain injury.
Readers interested in global medical cannabis policy, CBD mechanisms, and cannabis research in developing nations.
First FDA-approved cannabis medicine: Epidiolex for epilepsy
What the researchers found
CBD has an established role in treating epilepsy (FDA-approved Epidiolex) and emerging evidence for antipsychotic and neuroprotective properties, with the authors proposing potential adjunctive use for neuropsychological complications of malaria.
Why it matters
As Malawi joins the growing list of countries legalizing medical cannabis, this review frames the scientific evidence for CBD in a context relevant to local public health challenges, particularly malaria.
The numbers in context
Malawi legalized medical cannabis in February 2020; Epidiolex was the first FDA-approved cannabis-based treatment.
How the study worked
Special communication reviewing published literature on cannabis pharmacology, CBD mechanisms of action, FDA-approved treatments, and clinical research on CBD's antipsychotic and neuroprotective properties.
What this study cannot tell us
The proposal for CBD in malaria-related neuroprotection is speculative and lacks clinical evidence. The review is broad rather than systematic. Limited discussion of local implementation challenges.
How to read the evidence
Broad review with established evidence for epilepsy but speculative proposals for other conditions.
When this study was published
Published in 2022, contextualizing Malawi's 2020 cannabis legalization.
The bigger picture
The intersection of cannabis legalization in African nations with local disease burdens like malaria opens new research questions about whether cannabinoids could address region-specific health challenges.
Questions still open
- Could CBD actually provide neuroprotection in complicated malaria cases? What infrastructure does Malawi need to develop evidence-based medical cannabis programs?
Common questions
What is CBD's most established medical use?
What novel use does this review propose for CBD?
Read the original research
Medical cannabis and cannabidiol: A new harvest for Malawi.
Malawi medical journal : the journal of Medical Association of Malawi, 34(2), 138-142
Citation
Bandawe, Gama. (2022). Medical cannabis and cannabidiol: A new harvest for Malawi.. Malawi medical journal : the journal of Medical Association of Malawi, 34(2), 138-142. https://doi.org/10.4314/mmj.v34i2.10
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk